 |
|
|
|
Polen, Arı sütü , Propolis ve aldatmacalar |
Yanıt Yaz 
|
| Yazar | |
kıvanç 
Kıdemli Üye 
Kayıt Tarihi: 01 Eyl 2012 Konum: istanbul Durum: Aktif Değil Puanlar: 870 |
 Mesaj Seçenekleri
 Teşekkürler(0)
 Alıntı Cevapla
 Konu: Polen, Arı sütü , Propolis ve aldatmacalarGönderim Zamanı: 26 Eki 2020 Saat 17:43 |
Sayın hocam malüm bu günlerde çokça rağbet gören bu ürünler hakkındaki verdiğiniz bilgileri devamlı okuyor yararlanıyoruz. 1.sayfadaki sabitlenmiş makalenize cevap yazılmış ,belki gözünüzden kaçmıştır diye buraya alıntıladım ne dersiniz bu konuya. Çok teşekkür eder sağlıklı günler dilerim.😍 Düzenleyen kıvanç - 26 Eki 2020 Saat 17:47 |
|
|
Allahım yavrularımızı daima iyilerle karşılaştır .
|
|
 |
|
|
Dr.KadirTugcu
Uzman 
Kayıt Tarihi: 14 Ağu 2008 Durum: Aktif Değil Puanlar: 118286 |
Mesaj Seçenekleri
Yanıt Yaz
Alıntı Dr.KadirTugcu
Bu mesaj kurallara aykırıysa buradan yöneticileri bilgilendirebilirsiniz.
Teşekkürler(1)
Alıntı Cevapla
Gönderim Zamanı: 26 Eki 2020 Saat 19:33 |
|
Alin size Amerika'dan bir MAHKEME KARARI....
Bu sahtekarlarin iddialari ve mahkemenin bunlara tek tek cevabi!! Maalesef, Turkiye'de boyle makamlar olmadigi icin, bu gibi soytariliklar, Universitelerde bile uygulanabilmektedirler. Yok 3000 tane makale imis, yok kanser hastalarina veriliyormus!!! Hadi bakalim, bu mahkeme kararlarina da karsi bir sey soylesin bu sozum ona Prof. lar. Hala Turk Universite ve Prof. larini ciddiye aliyorsunuz.. Ayrica: Aci Badem sahtekarligini da bir okusaniza!! SAKIN: Turk Universite ve Prof. larini dikkate almayin. Department of Health and Human Services logo Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District Office 60 8th St., NE Atlanta, GA 30309 November 14, 2016 VIA UPS OVERNIGHT DELIVERY RETURN RECEIPT REQUESTED Ms. Beulah T. Loudermilk, Owner J. L. Bee Products, LLC 4008 Barrett Drive, Suite 205 Raleigh, NC 27609-6621 WARNING LETTER (17-ATL-02) Dear Ms. Loudermilk, The U.S. Food and Drug Administration (FDA or we) conducted an inspection of your facility located at 4008 Barrett Drive, Suite 205, Raleigh, NC from March 29-31, 2016. During the inspection we collected your product catalog as well as product labels for your Bee Pollen, Bee Propolis with Rose Hips, and Royal Jelly with Rose Hips products. The claims in your product catalog establish that your Bee Pollen, Bee Propolis with Rose Hips, and Royal Jelly with Rose Hips are drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(B)] because they are intended for use in the cure, mitigation, treatment, or prevention of disease. As explained further below, introducing or delivering these products for introduction into interstate commerce for such uses violates the Act. Additionally, your products are not labeled as dietary supplements, and therefore do not meet the definition of a dietary supplement. See section 201(ff)(2)(C) of the Act [21 U.S.C. § 321(ff)(2)(C)]. However, we note that your website, ww.jlbeeproducts.com, contains a statement that closely resembles the statement required under section 403(r)(6)(C) of the Act [21 U.S.C. § 343(r)(6)(C)], for dietary supplements that make certain labeling claims. Based on your use of this statement, it appears you may intend to market your Bee Pollen, Bee Propolis with Rose Hips, and Royal Jelly with Rose Hips products as dietary supplements. Even if these products were dietary supplements and not unapproved new drugs or misbranded drugs, they would be misbranded dietary supplements under 403 of the Act [21 U.S.C. § 343] and adulterated dietary supplements under 402(g)(1) of the Act [21 U.S.C. § 342(g)(1)] because the products have been prepared, packed, or held under conditions that do not meet the Current Good Manufacturing Practice (CGMP) regulations for dietary supplements in 21 Code of Federal Regulations Part 111 (21 CFR Part 111). You can find copies of the Act and pertinent regulations through links on FDA’s homepage at www.fda.gov. We acknowledge receipt of your written response dated April 5, 2016, to the FORM FDA 483, Inspectional Observations. Although your response includes descriptions of how you have corrected or intend to correct the identified deficiencies, we are not able to comment on the adequacy of your response because you have not provided us information with which to evaluate your corrective actions. Unapproved New Drugs and Misbranded Drugs Examples of some of the claims that provide evidence that your products are intended for use as drugs include: BEE POLLEN “In testimonials, Pollen has been shown to help with: Asthma…Anorexia, Constipation, Diarrhea… Prostatism and Impotence, Rheumatism & Arthritis, Colitis, Depression, Insomnia & Arteriosclerosis….” BEE PROPOLIS WITH ROSE HIPS “BEE PROPOLIS THE NATURAL HEALER AN INFECTION FIGHTER” “Bees use propolis as a …natural antibiotic.” “In testimonials, Propolis has been shown to help with: Internal Disease or Dysfunction, Infection or Viral Conditions, Colds & Influenza, Respiratory Distress, Mouth & Ear Infections, Sunburns, Ulcers & Digestive Disorders… Anemia, Burns, Gum and Tooth Problems….” “propolis has an antibiotic, disease fighting reaction to illness…” “men have used propolis to treat many physical ailments…sore throats, stomach problems, burns, open wounds, such as cuts and scrapes, and other inflammatory diseases.” “Today scientists confirm the outstanding antibiotic, antifungal, analgesic … and antiviral properties…” “numerous investigators have demonstrated that propolis has antimicrobial properties against various bacteria and fungi.” “Bee Propolis is most widely known for its natural antibiotic effect.” “Bee Propolis is an infection fighter.” ROYAL JELLY WITH ROSE HIPS “In testimonials Royal Jelly is also reported to . . . Increase Resistance to Disease…Vision Problems including Night Vision problems.” Your products are not generally recognized as safe and effective for the above referenced uses and, therefore, the products are “new drugs” under section 201(p) of the Act [21 U.S.C. § 321(p)]. New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from FDA, as described in sections 301(d) and 505(a) of the Act [21 U.S.C. §§ 331(d), 355(a)]. FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective. A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). “Adequate directions for use” means directions under which a layperson can use a drug safely and for the purposes for which it is intended (21 CFR 201.5). Prescription drugs, as defined in section 503(b)(1)(A) of the Act [21 U.S.C. § 353(b)(1)(A)], can only be used safely at the direction, and under the supervision, of a licensed practitioner. Your products Bee Pollen and Bee Propolis with Rose Hips are intended for treatment of one or more diseases that are not amenable to self-diagnosis or treatment without the supervision of a licensed practitioner. Therefore, it is impossible to write adequate directions for a layperson to use your products safely for their intended purposes. Accordingly, your Bee Pollen and Bee Propolis with Rose Hips products fail to bear adequate directions for their intended uses and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. § 331(a)]. Dietary Supplement CGMPs If your Bee Pollen, Bee Propolis with Rose Hips, and Royal Jelly with Rose Hips products were not unapproved new drugs or misbranded drugs, and if these products were properly labeled as dietary supplements, they would be adulterated dietary supplements under section 402(g)(1) of the Act [21 U.S.C. § 342(g)(1)] because the products were prepared, packed, or held under conditions that do not meet the CGMP regulation for dietary supplements in 21 CFR Part 111. During the inspection our FDA investigators observed the following significant violations of the CGMP regulations for dietary supplements: 1. You failed to establish and follow written procedures for the responsibilities of the quality control operations, including written procedures for conducting a material review and making a disposition decision, as required by 21 CFR 111.103. Specifically, you have not established and followed written procedures for performing quality control operations. We have reviewed your written response dated April 5, 2016, in which you stated that you have created a standard operating procedure manual. We are unable to determine the adequacy of your corrective actions because you have not provided us information with which to evaluate your corrective actions, such as a copy of the manual. Additionally, note that once you have established your quality control written procedures, you must implement quality control operations in your packaging, labeling, and holding operations for producing the dietary supplement to ensure the quality of the dietary supplement, as required by 21 CFR 111.65. 2. You failed to establish and follow written procedures to fulfill the requirements related to packaging and labeling operations, as required by 21 CFR 111.403. Specifically, you have no written procedures for your packaging and labeling operations. We have reviewed your written response dated April 5, 2016, in which you stated that you have created a standard operating procedure manual. We are unable to determine the adequacy of your corrective actions because you have not provided us information with which to evaluate your corrective actions, such as a copy of the manual. 3. You failed to fill, assemble, package, label, and perform other related operations in a way that ensures the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record, as required by 21 CFR 111.415. Specifically: • When packaging bee pollen into 120 count bottles on 03/30/16, you did not wash and sanitize the counting trays used to pour the capsules into the pill counting machine and subsequently into the empty bottle [21 CFR 111.415(a)]. • You did not clean and sanitize the work counter prior to using the workspace for packaging operations. On three occasions, you spilled capsules on the workbench and then picked them up and placed them into the product bottle [21 CFR 111.415(a)]. • You failed to assign a batch, lot, or control number to each lot of packaged and labeled dietary supplement from a finished batch of dietary supplement. Although your supplier provides a lot code on the Certificate of Analysis for each batch of dietary supplements sent to you, you do not place this code on, or assign a unique lot code of your own to, the labels used on the packaging of the repackaged dietary supplement product for sale [21 CFR 111.415(f)(1)]. We have reviewed your written response dated April 5, 2016, in which you stated that you have implemented a multi-step sanitation process in order to protect the products during packaging operations. Further, you stated that each box and bottle of product now contains lot numbers that correspond with the supplier lot numbers and may be traced to the Bulk Product Inventory Receipt Record. We are unable to evaluate the adequacy of your corrective actions because you have not provided us with information with which to evaluate your corrective actions, such as a copy of your cleaning procedure and records to support its implementation, and specific information regarding your new process for documenting lot numbers. 4. You failed to keep written records pertaining to product distribution for 1 year past the shelf life date, if shelf life dating is used, or 2 years beyond the date of distribution of the last batch of dietary supplements associated with those records, as required by 21 CFR 111.605(a). Specifically, you discard distribution records after three months. We have reviewed your written response dated April 5, 2016, in which you stated that a bulk product inventory receipt record is now in place that will be cross checked for quality control and the receiving and shipment records will be attached to the record and maintained for a minimum of two years. We are unable to evaluate the adequacy of your corrective actions because you have not provided us information with which to evaluate your corrective actions, such as a copy of your shipping and receiving procedure and documentation to support the implementation of the Bulk Product Inventory Receipt record. It is also unclear whether your response, if implemented, would satisfy the specific timeframes for recordkeeping established in 21 CFR 111.605(a), i.e., that the records be maintained for 1 year past the shelf life date, if shelf life dating is used, or 2 years beyond the date of distribution of the last batch of dietary supplements associated with those records. 5. You failed to establish specifications to provide sufficient assurance that the product you receive from a supplier for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier) is adequately identified and is consistent with your purchase order, as required by 21 CFR 111.70(f). Specifically, you have not established procedures for receiving product for packaging and labeling as a dietary supplement. We have reviewed your written response dated April 5, 2016, in which you stated that the procedures are now listed in your operations manual and that each product will contain the information required by the FDA when processed for shipping. We are unable to evaluate the adequacy of your corrective actions because you have not provided us with information with which to evaluate your corrective actions, such as a copy of the manual. 6. You failed to collect and hold reserve samples of each lot of packaged and labeled dietary supplement that you distribute, as required by 21 CFR 111.83(a). Specifically, you do not maintain reserve samples . We have reviewed your written response dated April 5, 2016, in which you stated that for each lot repacked a reserve sample will be set aside and will be kept for two years past the expiration date. We are unable to evaluate the adequacy of your corrective actions because you have not provided us with information with which to evaluate your corrective actions, such as a copy of your reserve sample handling procedure or other supporting records to demonstrate that the procedure has been implemented. 7. You failed to make and keep a written record of every product complaint related to good manufacturing practice, as required by 21 CFR 111.570(b)(2). Specifically, you do not keep a written record of each complaint received. We have reviewed your written response dated April 5, 2016, in which you stated that you will maintain a written record of any and all complaints that will reflect the nature of the complaint, other investigation information, and a follow-up to the complaint. We are unable to evaluate the adequacy of your corrective actions because you have not provided documentation of how your plan will be implemented. Misbranded Dietary Supplements If you intend to market your Bee Pollen, Bee Propolis with Rose Hips, and Royal Jelly with Rose Hips products as dietary supplements, our label review shows that these products are not properly labeled as dietary supplements. If you intend to market your products as dietary supplements, they must comply with the applicable statutory and regulatory requirements for dietary supplements. If these products were dietary supplements, they would be misbranded for the following reasons: 1. Your products would be misbranded within the meaning of section 403(s)(2)(B) of the Act, 21 U.S.C. § 343(s)(2)(B) because your product labels fail to identify the products using the term ”dietary supplement” in accordance with 21 CFR 101.3(g), which requires that a dietary supplement be identified by the term “dietary supplement” as part of the product’s statement of identity, except the word “dietary” may be deleted and replaced by the name of the dietary ingredient in the product or an appropriately descriptive term. 2. Your “Bee Propolis with Rose Hips and Royal Jelly with Rose Hips” products would be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343(s)(2)(C)]] because the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). 3. Your products would be misbranded within the meaning of section 403(i)(2) of the Act, 21 U.S.C. § 343(i)(2), because they are fabricated from two or more ingredients, and each ingredient is not declared on the label, as required by 21 CFR 101.4(b)(2). The ingredient list must be preceded by the word “Ingredients,” or ”Other Ingredients” in accordance with 21 CFR 101.4(g). The ingredients list must include not only the dietary ingredients but also the capsule ingredients for products in capsule form. 4. Your products would be misbranded within the meaning of section 403(q)(5)(F) of the Act [21 U.S.C. § 343(q)(5)(F)] because the labels fail to bear nutrition labeling (“Supplement Facts” panel), as required by 21 CFR 101.36. The violations cited in this letter are not intended to be an all-inclusive statement of violations that exist at your facility or in connection with your products. You are responsible for investigating and determining the causes of the violations identified above and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure that your firm complies with all requirements of federal law, including FDA regulations. You should take prompt action to correct all of the violations cited in this letter. Failure to promptly correct these violations may result in legal action without further notice, including, without limitation, seizure and injunction. Within fifteen working days of receipt of this letter, please notify this office in writing of the specific steps that you have taken to correct violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you cannot complete corrective actions within fifteen working days, state the reason for the delay and the time within which you will complete the correction. Your written response should be sent to the U.S. Food and Drug Administration, Attn: Janice L. King, Compliance Officer, at the address noted in the letterhead. If you have questions, please contact Mrs. King at 843-746-2990, x16 or write her at the noted address. Sincerely, /S/ Ingrid A. Zambrana District Director Atlanta District Office Düzenleyen Dr.KadirTugcu - 26 Eki 2020 Saat 19:34 |
|
|
|
|
Dr.KadirTugcu
Uzman
Kayıt Tarihi: 14 Ağu 2008 Durum: Aktif Değil Puanlar: 118286 |
Mesaj Seçenekleri
Yanıt Yaz
Alıntı Dr.KadirTugcu
Bu mesaj kurallara aykırıysa buradan yöneticileri bilgilendirebilirsiniz.
Teşekkürler(1)
Alıntı Cevapla
Gönderim Zamanı: 26 Eki 2020 Saat 20:56 |
|
Bu konu hakkinda bilgi edinmek isteyenler, asagidaki makaleyi okuyabilirler:
“Bee pollen” is actually pollen from flowers that is collected from bees as they enter the hive or is harvested by other means. Pollen granules stick to the bees’ legs and other body parts as they help themselves to nectar (the precursor of honey) inside the flowers. Pollen products are marketed through health-food stores, multilevel distributors, drugstores, mail-order advertising, and the Internet [A,B,C, D]. Misleading Claims Promoters call bee pollen “the perfect food” and stress that it contains all of the essential amino acids and many vitamins and minerals [1]. However, none of these nutrients offers any magic, and all are obtained easily and less expensively from conventional foods. The CC Pollen Company of Phoenix, Arizona, has also claimed: It has been estimated that honeybee pollen contains over 5,000 enzymes and coenzymes, many times more than any other food. . . . Enzymes in the body are not only necessary for perpetual healing and digestion but for life itself. Without enzymes, life is impossible. Also, enzymes protect against premature aging. It has been reliably stated that only honeybee pollen contains all known enzymes in perfect proportion and perfect balance. [1] The above statement is erroneous. Pollen does not contain all known enzymes, and even if it did, that would not contribute to human health. The enzymes in plants and other species of animals help regulate the metabolic functions of their respective species. When ingested, they do not act as enzymes within the human body, because they are digested rather than absorbed intact into the body. Bee pollen has also been claimed to improve athletic and sexual performance; slow the aging process; promote both weight loss and weight gain; prevent infection, allergy, and cancer; and alleviate more than 60 other health problems. No scientific study supports any claim that bee pollen is effective against any human disease. The few studies that have been done to test its effect on athletic performance have shown no benefit [2-4]. In the mid-1970s, for example, tests conducted on swimmers and cross-country runners found no difference in performance between those who took bee pollen and those who took a placebo [3]. A six-week study of 20 swimmers published in 1982 found no performance difference [4]. Royal jelly, which is secreted from the salivary glands of worker bees, serves as food for all young larvae and as the only food for larvae that will develop into queen bees. Like bee pollen, it has been falsely claimed to be especially nutritious, to provide buoyant energy, and to have therapeutic properties. Bee pollen and royal jelly should be regarded as potentially dangerous because they cause allergic reactions. People allergic to specific pollens have developed asthma, hives, and anaphylactic shock after ingesting pollen or royal jelly [5-12]. Neurologic and gastrointestinal reactions have also been reported [13,14]. Some cases of asthma and anaphylaxis have been fatal. The potential for serious reactions is widespread because at least 5% of Americans are allergic to ragweed pollen, and bee pollen contains pollen from ragweed or plants that cross-react with ragweed, such as dandelions, sunflowers, or chrysanthemums [15,16]. It has been speculated the presence of these allergens might enable regular users to become desensitized (as would happen with allergy shots). However, the odds of this happening are extremely small. Shots deliver the pollen in significant and controllable amounts, whereas bee pollen taken by mouth delivers unpredictable amounts that get digested [17]. Bees are exposed to various bacterial and chemical contaminants that might be incorporated in products for human consumption [18]. Although both bee pollen and royal jelly contain substances with antibiotic properties, both can sustain the growth of disease-causing organisms and neither has practical use as an antibiotic [19]. Contaminants can also be introduced during processing [18]. In 1995, Montana Naturals International, in Arlee, Montana, had to recall several thousand bottles of a bee pollen/royal jelly/propolis mix because of contamination with lead. Propolis, also called “bee glue,” is a resinous substance bees use to construct and maintain their hives. In laboratory tests, propolis has exhibited a variety of interesting antimicrobial and antitumor properties [20]. However, it has little practical use and can cause contact dermatitis and other allergic reactions [21]. Federal Enforcement Actions In 1990, the Federal Trade Commission (FTC) obtained a consent agreement barring American Life Nutrition and American LifeFarFun, Inc., from making various unsubstantiated claims for its bee pollen and four other products. In 1992, a federal court ordered destruction of quantities of Bee Alive, a royal jelly and herb combination in honey seized from Bee-Alive Inc., of Valley Cottage, N.Y. In 1989, the FDA had warned the company that promotional material distributed with a similar product had made illegal statements that the product was useful in treating or preventing chronic Epstein-Barr virus syndrome, gastrointestinal ulcers, colitis, low blood pressure, arteriosclerosis, nervous breakdowns, infertility, impotence, depression, rheumatoid arthritis, Alzheimer’s disease, anemia, asthma, hemorrhoids, migraine headaches, and other problems. Despite a promise to stop distributing literature making these claims, the company continued to advertise that Regina Royal Jelly could help children resist childhood ailments, “offers daytime vitality and nighttime tranquility,” increases mental and physical stamina, and “seems to improve the immune system.” Company president Madeline Balletta still promotes Bee-Alive as a “super-food” whose users (including herself) have been relieved from severe fatigue [22,23]. In 1994, the FTC obtained a consent agreement barring Bee-Sweet, Inc., a North Carolina-based firm, from claiming that its products could treat various physical ailments. Its ads had claimed that, “Studies performed by doctors around the world have shown bee pollen to be effective in treating illnesses from allergies to arthritis, anorexia to overweight, fatigue to arteriosclerosis.” In 1992, the CC Pollen Company and its owners (Bruce R. Brown, Carol M. Brown, and Royden Brown) agreed to pay $200,000 to settle charges that they falsely represented that bee-pollen products could produce weight loss, permanently alleviate allergies, reverse the aging process, and cure, prevent, or alleviate impotence or sexual dysfunction. The company and its owners were also charged with falsely stating that bee-pollen products are an effective antibiotic for human use and cannot result in an allergic reaction. Under the agreement, the company and its owners were prohibited from making all of these claims and are required to have scientific evidence to support any other health-related claims about any other product for human consumption. Some of the false claims were made in “infomercials” that were misrepresented as news or documentary programs, even though they were paid ads. During one infomercial, entitled “TV Insiders,” host Vince Inneo falsely implied that the program was part of a series of independent investigations. The products offered during the infomercial were Bee-Young, Pollenergy (to “restore missing energy’), Royal Jelly (“to keep sexually active at any age”), President’s Lunch, and First Lady’s Lunch Bar. The infomercial producer TV, Inc., signed a separate consent agreement. Although violation of an FTC consent agreement can trigger large penalties, Royden Brown continued to promote bee pollen illegally. In May 1994, S&S Public Relations Inc., of Chicago, issued a letter stating: “It’s allergy season, but many sufferers aren’t suffering anymore. They’re using Aller-Bee-Gone, bee pollen tablets that are credited with relieving the symptoms of allergies, asthma, and other respiratory ailments.” The accompanying news release added that Brown’s lifetime goal was “to eliminate degenerative disease worldwide through the use of bee pollen. However, a few weeks later, bee pollen’s most colorful promoter died following injuries sustained in a fall. For Additional Information Producing pollen (fact sheet from the University of Florida) References Is honeybee pollen the world’s only perfect food? (Booklet) Phoenix, AZ: CC Pollen Company, 1984. Steben RE, Boudroux P. The effects of pollen and pollen extracts on selected blood factors and performance of athletes. Journal of Sports Medicine and Physical Fitness 18:271-278, 1978. Larkin T. Bee pollen as a health food. FDA Consumer 18(3):21 22, 1984. Maughan RJ, Evans SP. Effects of pollen extract upon adolescent swimmers. British Journal of Sports Medicine 16:142-145, 1982. Thien FC and others. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy 26:216-222, 1996. Shaw D and others. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Safety 17:342-356, 1997. Prichard M, Turner KJ. Acute hypersensitivity to ingested processed pollen. Australian and New Zealand Journal of Medicine 15:346-347, 1985. Yonei Y and others. Case report: Haemorrhagic colitis associated with royal jelly intake. Journal of Gastroenterology and Hepatology 12:495-499, 1997. Geyman JP. Anaphylactic reaction after ingestion of bee pollen. Journal of the American Board of Family Practice 7:250-252, 1994. Mansfield LE, Goldstein GB. Anaphylactic reaction after ingestion of local bee pollen. Annals of Allergy 47:154-156, 1981. Lombardi C and others. Allergic reactions to honey and royal jelly and their relationship with sensitization to compositae. Allergologia et Immunopathologia 26:288-290, 1998. Leung R and others. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy 27:333-336, 1997. Lin FL and others. Hypereosinophilia, neurologic, and gastrointestinal symptoms after bee pollen ingestion. Journal of Allergy and Clinical Immunology 83:793-796, 1989. Puente S and others. Eosinophilic gastroenteritis caused by bee pollen sensitization. Medicina Clinica 108:698-700, 1997. Mirkin G. Can bee pollen benefit health? JAMA 262:1854, 1989. Helbling A and others. Allergy to honey: Relation to pollen and honey bee allergy. Allergy 47:41-49, 1992. Wandycz K. Allergies: Runny nose? Itchy throat? Bee pollen helps some allergy victims, but for most people it’s a waste of money. Forbes, April 25, 1995, p 414. Fleche C and others. Contamination of bee products and risk for human health: Situation in France. Revue Scientifique et Technique 16:609-19, 1997. Sanford MT. Pollen marketing. Fact Sheet ENY-118. Institute of Food and Agricultural Sciences, University of Florida. Feb 1995. Burdock GA. Review of the biological properties and toxicity of bee propolis. Food and Chemical Toxicology 36:347-363, 1998. Hausen BM and others. Propolis allergy (I): Origin, properties, usage and literature review. Contact Dermatitis 17:163-170, 1987. Ben Kinchlow and Madeline Balletta have a secret they want to share with you. They both have major responsibilities and hectic schedules. They both travel extensively. They have a secret . . . a God-given food that has already helped hundreds of thousands of Christians. Advertisement in Human Events, Aug 20, 1999, p 15. Bee-Alive Web site, Accessed Aug 22, 1999. |
|
|
|
|
Yanıt Yaz
|
|
Tweet
|
| Forum Atla | Forum İzinleri Sen Kapalı Foruma Yeni Konu Gönderme Sen Kapalı Forumdaki Konulara Cevap Yazma Sen Kapalı Forumda Cevapları Silme Sen Kapalı Forumdaki Cevapları Düzenleme Sen Kapalı Forumda Anket Açma Sen Kapalı Forumda Anketlerde Oy Kullanma |
|
Konu Seçenekleri
dythayriusta Yazdı: